Although Fc fusion strategy can improve the pharmacokinetics of ACE2 by extending the half‐life of free ACE2 and making the purification of recombinant proteins more convenient, ACE2‐IgG‐Fc may cause antibody‐dependent enhancement (ADE) during viral infection. Here, ACE2 is linked to viral infectious disease.